Current market catalysts

Billionaire Activist Investor Dan Loeb's Third Point Builds 4-Stock Bitcoin-To-AI Basket

Third Point built a four-stock basket of bitcoin miners positioned to benefit from the industry's growing shift toward AI infrastructure.

Bloomberg Reported SoftBank Seeks Another $10B Loan For OpenAI Stake Funding

https://www.bloomberg.com/news/articles/2026-08-28/softbank-seeks-another-10-billion-loan-for-openai-stake-funding

Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Elastic NV (ESTC) stock rose 21.8% in pre-market trading after reporting strong Q1 results and raising FY27 guidance. Other top gainers include WHLR, QNRX, AEMD, NA, SOLS, HYNE, GAP, AFRM, and ARKR. Top losers are BTAI, LGPS, FGL, HCWC, and KTCC.

Laurentian Bank of Canada Q3 Adj. EPS $0.51 Misses $0.63 Estimate, Sales $241.734M Miss $251.700M Estimate

Laurentian Bank of Canada (TSX:LB) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.63 by 19.05 percent. This is a 34.62 percent decrease over earnings of $0.78 per share

Berkshire Hathaway Cut Capital One Stake by 58% in Q2 — Billionaire Dan Loeb Is Doing the Exact Opposite

Berkshire slashed its Capital One stake by 58%, among its largest cuts, despite the stock's top growth score.

8-K filing — Belpointe PREP, LLC (OZ)

Filed: 2026-08-28 AccNo: 0001493152-26-040486 Size: 213 KB Item 8.01: Other Events

HC Wainwright & Co. Reiterates Buy on Bausch & Lomb, Maintains $21 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Bausch & Lomb (NYSE:BLCO) with a Buy and maintains $21 price target.

Netcapital Receives Nasdaq Delinquency Notice Over Delayed Fiscal 2026 Form 10-K Annual Report Filing

Quoin Pharmaceuticals Said Key Secondary Endpoint Of Global Impression of Change Also Achieved Statistical Significance At Week 12

Quoin Pharmaceuticals Announced Interim Analysis Of First Six Patients To Complete 12 Weeks Of Treatment Met Pre-Specified Alpha Adjusted Target For Primary Endpoint With Statistical Significance

8-K filing — BOXABL Inc. (BXBL)

Filed: 2026-08-28 AccNo: 0001493152-26-040483 Size: 481 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

HC Wainwright & Co. Maintains Buy on Generate Biomedicines, Raises Price Target to $30

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Generate Biomedicines (NASDAQ:GENB) with a Buy and raises the price target from $25 to $30.

8-K filing — Netcapital Inc. (NCPLW)

Filed: 2026-08-28 AccNo: 0001493152-26-040478 Size: 263 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits

BioXcel Therapeutics Announced That It Has Entered Into An Asset Sale Agreement With Teva Pharmaceuticals International For Substantially All Of The Company’s Assets

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Medtronic plc (NYSE: MDT) will release Q1 earnings on Sept. 1. Analysts predict $1.39 EPS and $9.54B revenue. Stock fell 2.2% to $89.97 on Aug. 27.

Quoin Pharmaceuticals Announced That It Has Entered Into A Securities Purchase Agreement With New And Existing Healthcare-focused Institutional Investors To Raise Up To Approximately $50M In Gross Proceeds

Jiayin Gr Q2 EPS $(0.52) Down From $1.36 YoY, Sales $108.603M Down From $263.304M YoY

Jiayin Gr (NASDAQ:JFIN) reported quarterly losses of $(0.52) per share. This is a 138.24 percent decrease over earnings of $1.36 per share from the same period last year. The company reported $108.603 million in sales

8-K filing — BioXcel Therapeutics, Inc. (BTAI)

Filed: 2026-08-28 AccNo: 0001104659-26-102570 Size: 209 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.03: Bankruptcy or Receivership

Performance Comparison: Amazon.com And Competitors In Broadline Retail Industry

In today's rapidly changing and fiercely competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies. In this article, we will conduct a comprehensive

In-Depth Analysis: Broadcom Versus Competitors In Semiconductors & Semiconductor Equipment Industry

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry

Understanding Apple's Position In Technology Hardware, Storage & Peripherals Industry Compared To Competitors

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating

Comparative Study: Microsoft And Industry Competitors In Software Industry

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a

Analyzing NVIDIA In Comparison To Competitors In Semiconductors & Semiconductor Equipment Industry

In today's rapidly changing and fiercely competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies. In this article, we will conduct a comprehensive

Cytokinetics Announced The Primary Results From ACACIA-HCM (Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-obstructive HCM), The Pivotal Phase 3 Clinical Trial Of Aficamten In Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Tesla's 500-Semi Einride Order Finally Gets a Timeline: '75 Approximately' This Year, CEO Says

Tesla to deliver 75 Semi trucks to Einride AB by 2026, with the rest by 2027. The order comes after Tesla received an initial order of 500 trucks.

CDT Equity Announced That New Solid Forms And Alternative Crystal Structures Of Its Existing Drug Compounds, Show Enhanced Physical Property Advantages, Including Improved Stability, Solubility, Manufacturability, Over Existing Forms Of These Compounds

UPDATE: IREN Q4 Adj. EPS $(0.74) Misses $(0.49) Estimate, Sales $137.200M Miss $142.320M Estimate

IREN (NASDAQ:IREN) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.49) by 51.02 percent. This is a 212.12 percent decrease over earnings of $0.66 per share from the same

Freecast Announced The Launch Of Beyond Media, A New Research And Industry Intelligence Series

Venezuela Plans to Exit OPEC as the US Eyes a Massive Stake in Caracas Oil Fields: Report

Venezuela is reportedly planning to leave OPEC, as Washington eyes a massive stake in Venezuelan oil fields.

MRVL Stock Plunges 8% in Premarket After Double Beat — Time to Buy the Dip? Analyst Nicholas Mugalli Says 'A Trillion-Dollar Company It Is!'

MRVL plunged 9% despite a Q2 beat due to margin fears. Is it time to buy the dip? One analyst says Marvell is a "trillion dollar company!"